UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future

Journal of molecular endocrinology, 2020-07, Vol.65 (1), p.T49-T63

2020

Volltextzugriff (PDF)

Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen

Clinical cancer research, 2017-04, Vol.23 (7), p.1710-1721

2017

Volltextzugriff (PDF)

The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer

Nature medicine, 2021-02, Vol.27 (2), p.310-320

2021

Volltextzugriff (PDF)

Cooperative Dynamics of AR and ER Activity in Breast Cancer

Molecular cancer research, 2016-11, Vol.14 (11), p.1054-1067

2016

Volltextzugriff (PDF)

New generation breast cancer cell lines developed from patient-derived xenografts

Breast cancer research : BCR, 2020-06, Vol.22 (1), p.68-68, Article 68

2020

Volltextzugriff (PDF)

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

Nature communications, 2022-04, Vol.13 (1), p.2011-2011, Article 2011

2022

Volltextzugriff (PDF)

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors

Breast cancer research : BCR, 2022-12, Vol.24 (1), p.88-88, Article 88

2022

Volltextzugriff (PDF)

The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis

Breast cancer research : BCR, 2016-12, Vol.18 (1), p.131, Article 131

2016

Volltextzugriff (PDF)

Separation of breast cancer and organ microenvironment transcriptomes in metastases

Breast cancer research : BCR, 2019-03, Vol.21 (1), p.36-36, Article 36

2019

Volltextzugriff (PDF)

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Breast cancer research and treatment, 2012-09, Vol.135 (2), p.415-432

2012

Volltextzugriff (PDF)

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

Proceedings of the National Academy of Sciences - PNAS, 2008-04, Vol.105 (15), p.5774-5779

2008

Volltextzugriff (PDF)

Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways

Breast cancer research : BCR, 2012-07, Vol.14 (4), p.R100-R100, Article R100

2012

Volltextzugriff (PDF)

The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p

Nature communications, 2015-12, Vol.6 (1), p.10077-10077, Article 10077

2015

Volltextzugriff (PDF)

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism

Cancers, 2022-03, Vol.14 (7), p.1776

2022

Volltextzugriff (PDF)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer

Cancers, 2023-06, Vol.15 (12), p.3179

2023

Volltextzugriff (PDF)

Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells

Journal of Mammary Gland Biology and Neoplasia, 2015-06, Vol.20 (1-2), p.39-50

2015

Volltextzugriff (PDF)

Estrogen receptor positive breast cancer metastasis : Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (18), p.9308-9315

2006

Volltextzugriff (PDF)

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer

Frontiers in oncology, 2017-05, Vol.7, p.94-94

2017

Volltextzugriff (PDF)

Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment

Journal of mammary gland biology and neoplasia, 2021-12, Vol.26 (4), p.399-417

2021

Volltextzugriff (PDF)

3300 Progesterone receptor alters lipid biology in luminal breast cancer

Journal of clinical and translational science, 2019-03, Vol.3 (s1), p.19-19

2019

Volltextzugriff (PDF)

Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer

British journal of cancer, 2021-01, Vol.124 (1), p.217-227

2021

Volltextzugriff (PDF)

Progesterone regulation of stem and progenitor cells in normal and malignant breast

Molecular and cellular endocrinology, 2012-06, Vol.357 (1-2), p.71-79

2012

Volltextzugriff (PDF)

Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer

Molecular cancer research, 2022-09, Vol.20 (9), p.1443-1455

2022

Volltextzugriff (PDF)

Progestins initiate a luminal to myoepithelial switch in estrogen- dependent human breast tumors without altering growth

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.9779-9788

2005

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Englisch
(105)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(59)
Life Sciences & Biomedicine
(59)
Female
(47)
Animals
(40)
Oncology
(40)
Breast Cancer
(36)
Mice
(35)
Breast Neoplasms - Pathology
(33)
Tumors
(27)
Cell Line, Tumor
(24)
Progesterone
(21)
Breast Neoplasms - Genetics
(20)
Estrogen Receptors
(19)
Receptors, Progesterone - Metabolism
(19)
Breast Neoplasms - Metabolism
(18)
Receptors, Estrogen - Metabolism
(17)
Biological And Medical Sciences
(15)
Breast Neoplasms - Drug Therapy
(15)
Estrogens
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future

Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen

The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer

Cooperative Dynamics of AR and ER Activity in Breast Cancer

New generation breast cancer cell lines developed from patient-derived xenografts

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors

The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis

Separation of breast cancer and organ microenvironment transcriptomes in metastases

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways

The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer

Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells

Estrogen receptor positive breast cancer metastasis : Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer

Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment

3300 Progesterone receptor alters lipid biology in luminal breast cancer

Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer

Progesterone regulation of stem and progenitor cells in normal and malignant breast

Patient-derived xenograft (PDX) models in basic and translational breast cancer research

Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer

Progestins initiate a luminal to myoepithelial switch in estrogen- dependent human breast tumors without altering growth

Suchergebnisse filtern